{"id":1017554,"date":"2026-11-05T08:39:29","date_gmt":"2026-11-05T13:39:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"modified":"2026-11-05T08:39:29","modified_gmt":"2026-11-05T13:39:29","slug":"eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","title":{"rendered":"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WATERTOWN, Mass., Nov.  05, 2026  (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, November 12, 2026 to report its third quarter 2026 financial results and highlight recent corporate developments.<\/p>\n<p>To access the live conference call, please register using the audio conference link: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=4LK8FlK9ykaJv0lru0fRQOsQiv6VotlvO46qPW3ac1oBYvbQ8ZFF_IG29QejIcUWiW3nF3ZU-IdI3J35L9Z8T3hv0VIxj8iXjIyUqwjz5hdOc2rALKb6LgpzI6DZyFGAYs4IntBd75LtWWTMcopFrZVaZpvPtqeHI8zeM_fzuTE=\" rel=\"nofollow\" target=\"_blank\">https:\/\/edge.media-server.com\/mmc\/p\/4ke9q689<\/a>. A live audio webcast of the event can be accessed via the Investors section of the Company website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=614ruwJIPkjXen1n6ECQoQ43oyFLjvGCpM_r8P99cL16fJTvty6toKfZpBgcffn_Xrfu-YmpP_92KcGIEFD13pwLpO5IAuhFC3NLEiPVvlQ=\" rel=\"nofollow\" target=\"_blank\">www.eyepoint.bio<\/a>. A webcast replay will also be available on the Company website at the conclusion of the call.<\/p>\n<p>\n        <strong>About EyePoint<\/strong>\n      <\/p>\n<p>EyePoint, Inc. (Nasdaq: EYPT) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases. The Company\u2019s lead product candidate, DURAVYU\u2122, is an innovative investigational sustained delivery treatment for serious retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor, with EyePoint\u2019s proprietary bioerodible Durasert E\u2122 sustained-delivery technology. DURAVYU is currently being evaluated in Phase 3 pivotal trials for diabetic macular edema (DME).<\/p>\n<p>The Company is committed to partnering with the retinal community to improve patient lives while creating long-term value, with four approved drugs over three decades and tens of thousands of eyes treated with EyePoint innovation.<\/p>\n<p>EyePoint is headquartered in Watertown, Massachusetts, with a commercial manufacturing facility in Northbridge, Massachusetts.<\/p>\n<p>Vorolanib is licensed to EyePoint exclusively by Equinox Sciences, a Betta Pharmaceuticals affiliate, for the localized treatment of all ophthalmic diseases outside of China, Macao, Hong Kong and Taiwan.<\/p>\n<p>\n        <em>DURAVYU<\/em><br \/>\n        <sup><br \/>\n          <em>\u2122<\/em><br \/>\n        <\/sup><br \/>\n        <em> has been conditionally accepted by the FDA as the proprietary name for EYP-1901. DURAVYU is an investigational product; it has not been approved by the FDA. FDA approval and the timeline for potential approval is uncertain.<\/em>\n      <\/p>\n<p>\n        <strong>Investors &amp; Media:<\/strong>\n      <\/p>\n<p>Robin Garner<br \/>VP, Corporate Communications &amp; Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pgDNiAGOBKWoCz00xtso9lG2acZiGT5P10SSUvY3G-driqM2h7_uSqXrxatDzbMCE5_kpP7Wn87Bs_gmpAkTipPymL32NwUzSRlIWcUYdD4=\" rel=\"nofollow\" target=\"_blank\">ir@eyepoint.bio<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzEyMzYzMDctN2QzZi00MWU2LTkzNGUtZGQ1N2I4YzUwZmIwLTEwMTczOTAtMjAyNi0xMS0wNS1lbg==\/tiny\/EyePoint-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WATERTOWN, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, November 12, 2026 to report its third quarter 2026 financial results and highlight recent corporate developments. To access the live conference call, please register using the audio conference link: https:\/\/edge.media-server.com\/mmc\/p\/4ke9q689. A live audio webcast of the event can be accessed via the Investors section of the Company website at\u00a0www.eyepoint.bio. A webcast replay will also be available on the Company website at the conclusion of the call. About EyePoint EyePoint, Inc. (Nasdaq: EYPT) &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1017554","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WATERTOWN, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, November 12, 2026 to report its third quarter 2026 financial results and highlight recent corporate developments. To access the live conference call, please register using the audio conference link: https:\/\/edge.media-server.com\/mmc\/p\/4ke9q689. A live audio webcast of the event can be accessed via the Investors section of the Company website at\u00a0www.eyepoint.bio. A webcast replay will also be available on the Company website at the conclusion of the call. About EyePoint EyePoint, Inc. (Nasdaq: EYPT) &hellip; Continue reading &quot;EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-05T13:39:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026\",\"datePublished\":\"2026-11-05T13:39:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"},\"wordCount\":334,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\",\"name\":\"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=\",\"datePublished\":\"2026-11-05T13:39:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","og_locale":"en_US","og_type":"article","og_title":"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk","og_description":"WATERTOWN, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) &#8212; EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, November 12, 2026 to report its third quarter 2026 financial results and highlight recent corporate developments. To access the live conference call, please register using the audio conference link: https:\/\/edge.media-server.com\/mmc\/p\/4ke9q689. A live audio webcast of the event can be accessed via the Investors section of the Company website at\u00a0www.eyepoint.bio. A webcast replay will also be available on the Company website at the conclusion of the call. About EyePoint EyePoint, Inc. (Nasdaq: EYPT) &hellip; Continue reading \"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-05T13:39:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026","datePublished":"2026-11-05T13:39:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"},"wordCount":334,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/","name":"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=","datePublished":"2026-11-05T13:39:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MTEyMiM3OTQ4MTI0IzIwMDU4MTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/eyepoint-to-report-third-quarter-2026-financial-results-on-november-12-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EyePoint to Report Third Quarter 2026 Financial Results on November 12, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1017554","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1017554"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1017554\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1017554"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1017554"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1017554"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}